Taro-Zoledronic acid injection drug, used for osteoporosis and Page's disease, recalled because it may contain particulate matter

Product quality

Date

2022-08-09

Country

Canada

Product

Taro-Zoledronic acid injection 5mg/100mL (DIN 02415100)

Category

Drugs & medical

Source

Health Canada

Copied automatically from the Government of Canada. Details may be shortened or out of date; the official notice is the authoritative source. Disclaimer

What to do

1. Check the product name, strength and lot number against the official notice.
2. Do not stop a prescribed medicine without talking to your doctor or pharmacist first.
3. Ask the pharmacy or supplier about a replacement or refund.

General guidance from Recall Atlas. The official notice from the Government of Canada has the exact models, batch codes and remedy, and it takes priority.

Other drugs & medical recalls in Canada

1. 2022-08-15
2. CA
   Drugs & medicalType II

   Zero Tolerance Plus Sanitizer: Contains undeclared impurity at elevated levels.

   Product quality - COVID

   Health CanadaOfficial notice →
3. CA
   Drugs & medicalType II

   Cobas Analytical and Supply Unit

   Performance

   Health CanadaOfficial notice →
4. 2022-08-10
5. CA
   Drugs & medicalType I

   Taro-Zoledronic Acid: The affected lots may contain particulate matter

   Product quality

   Health CanadaOfficial notice →
6. 2022-08-08
7. CA
   Drugs & medicalType I

   JAMP-ATORVASTATIN: The affected lot may contain latex.

   Contamination

   Health CanadaOfficial notice →
8. CA
   Drugs & medicalType II

   BD Maxguardtm Extension Sets

   Labelling and packaging

   Health CanadaOfficial notice →
9. CA
   Drugs & medicalType II

   Microclave Clear Sets

   Performance

   Health CanadaOfficial notice →